Which has grown faster, CGEN or KROS?

Over the past five years, KROS grew revenue faster — CGEN at a 105.91% CAGR versus KROS at 172.50%.

Is CGEN or KROS more profitable?

CGEN runs the higher net margin — CGEN at 47.55% versus KROS at -553.88%.

How have CGEN and KROS total returns compared?

Over the past 5 years, CGEN delivered -18.39% and KROS delivered -21.98% annualized total return. Past performance doesn't predict future results.

Compugen Ltd. (CGEN) vs Keros Therapeutics, Inc. (KROS)

A side-by-side comparison of Compugen Ltd. and Keros Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CGEN

Compugen Ltd.

$211M

$2.24HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT

KROS

Keros Therapeutics, Inc.

$222M

$11.22HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT

Total return — CGEN vs KROS

growth of $100 · dividends reinvested · last 6y

CGEN -71.6% (-18.9%/yr)KROS -42.6% (-8.8%/yr)KROS compounded faster over this window

CGEN KROS

CGEN vs KROS: by the numbers

•KROS is the larger company ($222M vs $211M market cap).
•CGEN is profitable (47.55% net margin) while KROS runs a net loss (-553.88%).
•KROS grew revenue faster over the past five years (172.50% vs 105.91% CAGR).

Metrics side by side

Valuation

Metric	CGEN	KROS
P/E ratio	5.95	N/A
P/S ratio	2.86	14.82
P/B ratio	2.38	0.85

Profitability

Metric	CGEN	KROS
Gross margin	86.89%	94.68%
Operating margin	40.94%	28.94%
Net margin	47.55%	-553.88%
ROE	39.66%	-31.70%
ROIC	26.14%	-36.49%

Growth (annualized)

Metric	CGEN	KROS
Revenue CAGR (5Y)	105.91%	172.50%
Total return CAGR (5Y)	-18.39%	-21.98%

Frequently asked

Which has grown faster, CGEN or KROS?: Over the past five years, KROS grew revenue faster — CGEN at a 105.91% CAGR versus KROS at 172.50%.
Is CGEN or KROS more profitable?: CGEN runs the higher net margin — CGEN at 47.55% versus KROS at -553.88%.
How have CGEN and KROS total returns compared?: Over the past 5 years, CGEN delivered -18.39% and KROS delivered -21.98% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CGEN analysis Full KROS analysis Interactive comparison tool

Dig into the metrics

Compugen P/E ratio Compugen ROE Keros Therapeutics ROE Compugen operating margin Keros Therapeutics operating margin Compugen revenue growth Keros Therapeutics revenue growth Compugen free cash flow Keros Therapeutics free cash flow

Compugen & Keros Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.